Peroxitech Announces Closing Of $25M Series A Financing To Develop Novel Treatment For Acute Lung Injury
Amount Raised
$25 Million
Round Type
Series A
PhiladelphiaBiotechnologyHealth CareTherapeuticsInvestors
Description
Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (“PXV Fund”). The company will use the proceeds to build upon the preclinical work conducted through collaborative partnership and seed investment with the Xontogeny development team to advance the lead candidate, PIP-2, through IND-enabling studies and into clinical development.
Quick answer
Peroxitech raised $25 Million in a Series A round, dated December 13, 2022. Investors: Perceptive Xontogeny Venture Fund. Peroxitech is based in Philadelphia, Pennsylvania, United States.
- How much did Peroxitech raise?
- Peroxitech raised $25 Million in a Series A round on December 13, 2022.
- Who invested in Peroxitech?
- Perceptive Xontogeny Venture Fund is named as investors in this round.
- What does Peroxitech do?
- Peroxitech Inc. is a privately held biopharmaceutical company focused on the development and commercialization of a novel therapeutic for treatment of acute lung injury.
- Where is Peroxitech based and how big is it?
- Peroxitech is based in Philadelphia, Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Peroxitech that raised within 45 days of this round, from Fundz verified event records.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M on January 26, 2023.
- HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
- Apexigen raised $2.8M (Seed) on January 24, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
Who to call at Peroxitech, and when
A new round usually means Peroxitech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Peroxitech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Peroxitech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Peroxitech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Peroxitech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansPeroxitech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.